Jenzer, Maximilian
Keß, Peter
Nientiedt, Cathleen
Endris, Volker
Kippenberger, Maximilian
Leichsenring, Jonas
Stögbauer, Fabian
Haimes, Josh
Mishkin, Skyler
Kudlow, Brian
Kaczorowski, Adam
Zschäbitz, Stefanie
Volckmar, Anna-Lena
Sültmann, Holger
Jäger, Dirk
Duensing, Anette
Schirmacher, Peter
Hohenfellner, Markus
Grüllich, Carsten
Stenzinger, Albrecht
Duensing, Stefan http://orcid.org/0000-0001-7840-138X
Funding for this research was provided by:
Medizinischen Fakultät Heidelberg, Universität Heidelberg
Article History
Received: 30 October 2018
Accepted: 5 September 2019
First Online: 23 September 2019
Compliance with ethical standards
:
: The authors declare that they have no potential conflict of interest.
: All tissue-based experiments in this study were in accordance with the regulations of the tissue bank and with the approval of the ethics committee of the University of Heidelberg School of Medicine (206/2005, 207/2005, S-085/2012). Targeted next-generation sequencing was performed under the approval of the ethics committee of the University of Heidelberg School of Medicine (S-051/2017).
: Patients provided written informed consent for the use of their tissue specimens and clinical data for research and publication prior to undergoing radical prostatectomy at the Department of Urology of the University of Heidelberg. Patients that were part of the targeted NGS panel cohort provided written informed consent for the use of tissue specimens and clinical data for research and publication prior to prostate biopsy and, in addition, written informed consent for participation in the prospective study registered under registration number DRKS00015159 in the German Clinical Trials Register (DRKS), an approved primary register of the WHO fulfilling the requirements of the International Committee of Medical Journal Editors (ICMJE).